Cargando…
Heterologous prime-boost immunization co-targeting dual antigens inhibit tumor growth and relapse
Therapeutic cancer vaccines aim to induce an effective immune response against cancer, and the effectiveness of these vaccines is influenced by the choice of immunogen, vaccine type, and immunization strategy. Although treatment with cancer vaccines can improve tumor burden and survival, in most ani...
Autores principales: | Guo, Qianqian, Wang, Lizheng, Xu, Ping, Geng, Fei, Guo, Jie, Dong, Ling, Bao, Xin, Zhou, Yi, Feng, Mengfan, Wu, Jiaxin, Wu, Hui, Yu, Bin, Zhang, Haihong, Yu, Xianghui, Kong, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657584/ https://www.ncbi.nlm.nih.gov/pubmed/33224629 http://dx.doi.org/10.1080/2162402X.2020.1841392 |
Ejemplares similares
-
Heterologous prime boost COVID 19 vaccination
por: Launay, O., et al.
Publicado: (2022) -
CAFs/tumor cells co-targeting DNA vaccine in combination with low-dose gemcitabine for the treatment of Panc02 murine pancreatic cancer
por: Geng, Fei, et al.
Publicado: (2022) -
A tropism-transformed Oncolytic Adenovirus with Dual Capsid Modifications for enhanced Glioblastoma Therapy
por: Wang, Lizheng, et al.
Publicado: (2020) -
Heterologous prime-boost: an important candidate immunization strategy against Tembusu virus
por: Pan, Yuting, et al.
Publicado: (2020) -
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System
por: Ciabattini, Annalisa, et al.
Publicado: (2018)